The Patent Finder

Welichem Biotech Inc.

Also on record
Records under this name other than the patents Welichem Biotech Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Showing 1 to 10 of 10 · Back to Welichem Biotech Inc.

Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleStatus Expires Confidence
US 8,487,009Novel 1,2-Diphenylethene Derivatives for Treatment of Immune Diseases
Formerly held
Term ended
Term ended Apr 4, 2023 · Medium confidence
Term endedTerm ended Apr 4, 2023Medium confidence
US 7,321,050Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues
Formerly held
Term ended
Term ended Dec 25, 2022 · Medium confidence
Term endedTerm ended Dec 25, 2022Medium confidence
US 7,868,047Anti-Inflammatory and Psoriasis Treatment and Protein Kinase Inhibition by Hydroxy Stilbenes and Novel Stilbene Derivatives and Analogues
Formerly held
Term ended
Term ended Dec 6, 2020 · Medium confidence
Term endedTerm ended Dec 6, 2020Medium confidence
US 8,071,637Dithiolopyrrolones compounds and their therapeutic applications
Lapsed on the fee record
Ended Dec 6, 2019 · USPTO record
Lapsed on the fee recordEnded Dec 6, 2019USPTO record
US 9,051,330Dithiolopyrrolones with therapeutic activity
Lapsed on the fee record
Ended Jun 9, 2019 · USPTO record
Lapsed on the fee recordEnded Jun 9, 2019USPTO record
US 6,583,171Antineoplastic agents
Term ended
Term ended Apr 4, 2016 · USPTO record
Term endedTerm ended Apr 4, 2016USPTO record
US 6,316,476Heterocyclic compounds with antibacterial and antimycotic properties
Lapsed on the fee record
Ended Nov 13, 2013 · USPTO record
Lapsed on the fee recordEnded Nov 13, 2013USPTO record
US 6,020,360Anticancer property of dithiolopyrrolones
Lapsed on the fee record
Ended Feb 1, 2012 · USPTO record
Lapsed on the fee recordEnded Feb 1, 2012USPTO record
US 5,569,668Indole derivatives with antibacterial and antimycotic properties
Term ended
Term ended no later than Oct 29, 2016 · Low confidence
Term endedTerm ended no later than Oct 29, 2016Low confidence
US 5,827,872Xenomins novel heterocyclic compounds with antimicrobial and antneoplastic properties
Term ended
Term ended no later than Oct 27, 2018 · Low confidence
Term endedTerm ended no later than Oct 27, 2018Low confidence
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited